Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;33:698-702

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Niu, T.
Right arrow Articles by Xu, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Niu, T.
Right arrow Articles by Xu, X.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
Related Collections
Right arrow Other hypertension
Right arrow Genomics

(Hypertension. 1999;33:698-702.)
© 1999 American Heart Association, Inc.


Scientific Contributions

Angiotensinogen Gene Polymorphisms M235T/T174M

No Excess Transmission to Hypertensive Chinese

Tianhua Niu; Jianhua Yang; Binyan Wang; Wei Chen; Zhaoxi Wang; Nan Laird; Eric Wei; Zhian Fang; Klaus Lindpaintner; John J. Rogus; Xiping Xu

From the Program for Population Genetics, Harvard School of Public Health (T.N., B.W., Z.W., E.W., J.J.R., X.X.); Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School (T.N., K.L); Division of Biological Sciences, Harvard School of Public Health (T.N., X.X.), Boston, Mass; Anhui MEIZHONG Institute for Biomedical Sciences and Environmental Health, Anhui, China (J.Y., W.C., Z.F., X.X.); The Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School (X.X.); Department of Biostatistics, Harvard School of Public Health (N.L.), Boston, Mass; Max Delbrück Centre for Molecular Medicine, Berlin, Germany (K.L.).

Correspondence and reprint requests to Xiping Xu, MD, FXB-101, Harvard School of Public Health, 665 Huntington Ave, Boston, MA 02115-6096. E-mail xxu{at}ppg.harvard.edu

Abstract—The gene encoding angiotensinogen (AGT) has been widely studied as a candidate gene for hypertension. Most studies to date have relied on case-control analysis to test for an excess of AGT variants among hypertensive cases compared with normotensive controls. However, with this design, nothing guarantees that a positive finding is due to actual allelic association as opposed to an inappropriate control population. To avoid this difficulty in our study of essential hypertension in Anqing, China, we tested AGT variants using the transmission/disequilibrium test, a procedure that bypasses the need for a control sample by testing for excessive transmission of a genetic variant from parents heterozygous for that variant. We analyzed two AGT polymorphisms, M235T and T174M, which have been associated with essential hypertension in whites and Japanese, using data on 335 hypertensive subjects from 315 nuclear families and their parents. Except in the group of subjects younger than 25 years, M235 and T174 were the more frequently transmitted alleles. We found that 194 parents heterozygous for M235T transmitted M235 106 times (P=0.22) and that 102 parents heterozygous for T174M transmitted T174 60 times (P=0.09). Stratifying offspring by gender, M235 and T174 were transmitted 60 of 106 times (P=0.21) and 44 of 75 times (P=0.17), respectively, in men, and 46 of 88 times (P=0.75) and 16 of 27 times (P=0.44), respectively, in women. Our results were also negative in all age groups and for the affected offspring with blood pressure values >=160/95 mm Hg. Thus, this study provides no evidence that either allele of M235T or T174M contributes to hypertension in this Chinese population.


Key Words: angiotensinogen • hypertension, essential • transmission/disequilibrium test




This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
S. Oparil, M. A. Zaman, and D. A. Calhoun
Pathogenesis of Hypertension
Ann Intern Med, November 4, 2003; 139(9): 761 - 776.
[Full Text] [PDF]


Home page
NeurologyHome page
A. Hassan, P. C. Sham, and H. S. Markus
Planning genetic studies in human stroke: Sample size estimates based on family history data
Neurology, May 28, 2002; 58(10): 1483 - 1488.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. Schmidt, F. Fazekas, G. M. Kostner, C. M. van Duijn, and R. Schmidt
Angiotensinogen Gene Promoter Haplotype and Microangiopathy-Related Cerebral Damage : Results of the Austrian Stroke Prevention Study
Stroke, February 1, 2001; 32(2): 405 - 412.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. Ishikawa, S. Baba, T. Katsuya, N. Iwai, T. Asai, M. Fukuda, S. Takiuchi, Y. Fu, T. Mannami, J. Ogata, et al.
T+31C Polymorphism of Angiotensinogen Gene and Essential Hypertension
Hypertension, February 1, 2001; 37(2): 281 - 285.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
A. Hassan and H. S. Markus
Genetics and ischaemic stroke
Brain, September 1, 2000; 123(9): 1784 - 1812.
[Abstract] [Full Text] [PDF]